Saudi Medical Journal. 2006; 27 (10): 1523-1525
em Inglês
| IMEMR
| ID: emr-80607
ABSTRACT
Production of fetal proteins by malignant tissue is a recognized phenomenon seen in many neoplastic disorders. Hence, the aim was to determine if there is a positive correlation between administration of chemotherapy and reduction in fetal hemoglobin [HbF] levels. In a prospective study at the University of Benin Teaching Hospital, Nigeria, 50 cancer patients at various stages of the disease and 50 controls for 10 months period [March to December, 2005], HbF was determined in pre- chemotherapy [n=23] and post-chemotherapy [n=27] cancer patients. Fetal hemoglobin was estimated by the modified Betke's method. A total of 20 patients [40%] comprising 10 pre-chemotherapy and 10 post-chemotherapy patients presented with increased HbF which was statistically significant [p<0.0001]. There was also a significant decrease in post- chemotherapy result when both pre and post-chemotherapy values were compared [p=0.0073]. The results presented indicate that during recovery of erythropoiesis some erythroblasts synthesized HbF and there was a reduction following administration of chemotherapy
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Sedimentação Sanguínea
/
Hemoglobina Fetal
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Estudos Prospectivos
/
Resultado do Tratamento
/
Neoplasias
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Saudi Med. J.
Ano de publicação:
2006
Similares
MEDLINE
...
LILACS
LIS